Literature DB >> 9017533

Cognition, negative symptoms, and diagnosis: a comparison of schizophrenic, bipolar, and control samples.

K A Hawkins1, R E Hoffman, D M Quinlan, J Rakfeldt, N M Docherty, W H Sledge.   

Abstract

Forty-six schizophrenic, 22 bipolar, and 26 normal control subjects were administered negative and positive symptoms scales and tests of cognitive function. Test performance was related to diagnosis and to positive and negative symptom ratings within the schizophrenic group. Bipolar patients were significantly superior in cognitive status when compared with all schizophrenic patients, but less so when compared only with those who did not have key negative symptoms (affective nonresponsivity and poverty of speech). The schizophrenic patients with negative symptoms displayed severe impairment, performing significantly worse than the control, bipolar, and other schizophrenic subjects. Negative symptoms thus are significantly implicated in the cognitive inferiority of schizophrenic to bipolar patients. Although the data suggest bipolar patients may also have cognitive deficiencies, these findings are inconclusive and require cross-validation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9017533     DOI: 10.1176/jnp.9.1.81

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  13 in total

1.  Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder.

Authors:  Tessa Christodoulou; Lambros Messinis; Panagiotis Papathanasopoulos; Sophia Frangou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-04-22       Impact factor: 5.270

Review 2.  [Cognitive disorders in schizophrenic patients].

Authors:  H-P Volz; F Reischies; M Riedel
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

3.  Prospective predictors of mood episodes in bipolar disorder.

Authors:  Julia W Y Kam; Amanda R Bolbecker; Brian F O'Donnell; William P Hetrick; Colleen A Brenner
Journal:  J Affect Disord       Date:  2011-07-23       Impact factor: 4.839

4.  Memory deficits in patients with schizophrenia: preliminary data from the Wechsler Memory Scale-Third Edition support earlier findings.

Authors:  K A Hawkins
Journal:  J Psychiatry Neurosci       Date:  1999-09       Impact factor: 6.186

5.  A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state.

Authors:  Matthew M Kurtz; Raphael T Gerraty
Journal:  Neuropsychology       Date:  2009-09       Impact factor: 3.295

Review 6.  Should cognitive deficit be a diagnostic criterion for schizophrenia?

Authors:  Ralph Lewis
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

7.  Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.

Authors:  Michael Riedel; Norbert Müller; Ilja Spellmann; Rolf R Engel; Richard Musil; Rosamaria Valdevit; Sandra Dehning; Anette Douhet; Anja Cerovecki; Martin Strassnig; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-10       Impact factor: 5.270

8.  Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Authors:  Michael Riedel; Ilja Spellmann; Martin Strassnig; Anette Douhet; Sandra Dehning; Markus Opgen-Rhein; Rosamaria Valdevit; Rolf R Engel; Nikolaus Kleindienst; Norbert Müller; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-07-14       Impact factor: 5.270

9.  Effectiveness and tolerability of warm-supplementing kidney yang added to risperidone in improving cognitive impairment in patients with schizophrenia: An 8-week, multicenter, randomized, double-blind, placebo-controlled clinical trial.

Authors:  Zhen-Hua Chen; Gao-Hua Wang; Xiao-Ping Wang; Ren-Yun Chen; Hui-Lin Wang; Ming-Hua Yang; Yun-Xiang Huo; Hong-Bing Mei
Journal:  Curr Ther Res Clin Exp       Date:  2008-04

10.  Persistence, diagnostic specificity and genetic liability for context-processing deficits in schizophrenia.

Authors:  Annette E Richard; Cameron S Carter; Jonathan D Cohen; Raymond Y Cho
Journal:  Schizophr Res       Date:  2013-04-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.